Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chlamydia
Study findings on chlamydia are outlined in reports from P.N. Levett and colleagues
October 9th, 2008
"A total of 500 first-void urine specimens were tested for the presence of Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acids using ProbeTec ET reagents on a Viper platform ( BD Diagnostics, Mississauga, Ontario, Canada), Aptima Combo 2 reagents on a Tigris platform (Gen-Probe, Inc., San Diego, CA), and Abbott RealTime CT/NG reagents on an m2000 platform ( Abbott Molecular Diagnostics, Des Plaines, IL)," investigators in Regina, Canada report. "The performance of the three assays for detection of N. gonorrhoeae was comparable, but detection of C. trachomatis by the three assays showed more variation," wrote P.N. Levett and colleagues. The...
Source: Women's Health Weekly (2008-10-09)
|
